| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,740 | 1,840 | 16:38 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 02.11. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 26.10. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 26.10. | HAOHAI BIOTEC 9M Net Profit Falls 46.53% YoY to RMB163 million | 2 | AASTOCKS | ||
| 23.10. | HAOHAI BIOTEC (06826): 2026 THIRD QUARTERLY REPORT | 1 | HKEx | ||
| 12.10. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 1 | HKEx | ||
| 18.09. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 09.09. | HAOHAI BIOTEC (06826): (REVISED) NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 08.09. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
| 07.09. | HAOHAI BIOTEC (06826): INTERIM REPORT 2026 | 1 | HKEx | ||
| 04.09. | Dividendenbekanntmachungen (04.09.2026) | 16.470 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,086 EUR ACUSHNET HOLDINGS CORP US0050981085 0,255 USD 0,2193 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
| 01.09. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 24.08. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.08. | Shanghai Haohai Biological Technology Co., Ltd Profit Retreats In H1 | 2 | RTTNews | ||
| 21.08. | HAOHAI BIOTEC (06826): CHANGE OF AUTHORIZED REPRESENTATIVE | - | HKEx | ||
| 21.08. | HAOHAI BIOTEC (06826): DISTRIBUTION AND PAYMENT OF 2026 INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS | 1 | HKEx | ||
| 21.08. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2026 | - | HKEx | ||
| 11.08. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 5 | HKEx | ||
| 20.07. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 22.06. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AMGEN | 400,55 | -0,94 % | Piper Sandler raises Amgen stock price target on pipeline potential | ||
| VALNEVA | 2,470 | +1,19 % | Valneva im Check: Starke Shigella-Daten - reicht der Schwung? | ||
| STRYKER | 285,10 | -1,66 % | Stryker: 178,92-Millionen-Verkauf - was steckt dahinter? | ||
| REGENERON PHARMACEUTICALS | 846,30 | -1,74 % | Regeneron-Aktie: Erneute Aufwärtsbewegung nach Konsolidierung | Nach den jüngsten Quartalsergebnissen erreichte Regeneron ein neues Jahreshoch, bevor eine Konsolidierung einsetzte. Die anschließende Kurserholung hat ein höheres Tief hinterlassen, während das bisherige... ► Artikel lesen | |
| CSL | 122,12 | +2,09 % | CSL LIMITED: Update - Notification of buy-back - CSL | ||
| BEONE MEDICINES LTD ADR | 366,00 | -0,54 % | If You Invested $100 In BeOne Medicines Stock 10 Years Ago, You Would Have This Much Today | ||
| CANSINO BIOLOGICS | 2,440 | 0,00 % | CANSINOBIO Td5cp Approved for Clinical Trials in China Among Children Aged 4-5 | ||
| BIOMERIEUX | 91,75 | 0,00 % | Exor-Institut Mérieux-bioMérieux Press Release | ||
| SINO BIOPHARM | 0,611 | -2,19 % | CMBI Raises SBP GROUP TP to HKD9 as Multiple Innovative Drugs Included in National Medical Insurance | ||
| ZAI LAB LTD ADR | 21,200 | +4,95 % | Zai Lab auf Jefferies Global Healthcare Conference: Pipeline nähert sich strategischem Wendepunkt | ||
| CSTONE PHARMACEUTICALS | 0,641 | -2,64 % | CStone Pharmaceuticals: CStone and Kimia Therapeutics Enter Clinical Development Collaboration to Advance a Novel Drug Candidate Targeting Repair Pathways Critical for Solid Tumor Survival | SUZHOU, China, Nov. 3, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology... ► Artikel lesen | |
| CASI PHARMACEUTICALS | 0,214 | -4,13 % | CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results | SOUTH SAN FRANCISCO, CA / ACCESS Newswire / August 14, 2026 / CASI Pharmaceuticals, Inc. (OTCQB:CASIF), a clinical-stage biopharmaceutical company developing CID-103, an anti-CD38 monoclonal antibody... ► Artikel lesen | |
| 3SBIO | 1,562 | +2,49 % | 3SBio Inc.: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth | SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded... ► Artikel lesen | |
| QIAGEN | 45,200 | 0,00 % | QIAGEN N.V.: QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that shareholders overwhelmingly approved the appointment of Jonathan M. Pratt as a Managing Director and member of the QIAGEN... ► Artikel lesen | |
| CG ONCOLOGY | 82,85 | +3,56 % | Guggenheim raises CG Oncology stock price target on trial results |